This document summarizes the small hospital EHR/HIS vendor market. It notes that Evident recently acquired Healthland, expanding its client base to over 1,000 small hospitals. Athenahealth and eClinicalWorks recently entered the small hospital market after focusing on physician practices. Other players for small hospitals include Meditech, Cerner, and Allscripts which offer cheaper versions of their products for this market. The document predicts continued consolidation in this space as large vendors look to gain more market share.
This talks about embedded training to students and hobbyists by Vinay Chaddha using a methodology which is lot different from what is normally used by training colleges.
THIS PRESENTATION TALKS ABOUT THE KEY ELEMENTS REQUIRED FOR A HOSPITAL MARKETING PLAN. THIS CAN BE USED AS A REFERENCE FOR OTHER SERVICE MARKETING INDUSRTIES.
THANKS
REYAZ K SIDDIQUI
This is a high level view of aspects of sales and marketing for hospitals. There would be variations and details based on the actual hospital, specialties, service area demographic etc.
The slide is all about Healthcare Marketing. How you can develop marketing strategies in healthcare market.
Healthcare is booming industry & in accordance with marketing concepts it is very necessary to do marketing of services.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
COVID-19 PCR tests remain a critical component of safe and responsible travel in 2024. They ensure compliance with international travel regulations, help detect and control the spread of new variants, protect vulnerable populations, and provide peace of mind. As we continue to navigate the complexities of global travel during the pandemic, PCR testing stands as a key measure to keep everyone safe and healthy. Whether you are planning a business trip, a family vacation, or an international adventure, incorporating PCR testing into your travel plans is a prudent and necessary step. Visit us at https://www.globaltravelclinics.com/
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
This document is designed as an introductory to medical students,nursing students,midwives or other healthcare trainees to improve their understanding about how health system in Sri Lanka cares children health.
2. Small Hospital Vendors
• Our vendor review ends with those targeting:
– Small hospitals of under 100 beds, including
Critical Access Hospitals (CAH) of <25 beds
– Before you dismiss this “tiny” market, realize
there are over 1,300 CAH hospitals in the US,
– Plus another ≈1,000 from 25 to 100 beds, so
this “small” market has a large footprint!
• This episode covers those vendors’:
- Revenue growth/decline & history
- Products & client bases by bed size
- Recent mergers & acquisitions
- New entrants & surprise departures
- Candid assessment of future prospects
3. • Computer Programming & Systems, Inc. – CPSI was re-branded
as Evident last year, evidently proving something to Wall Street…
• Their
revenue
dropped by
≈11% in
2015, which
explains the
biggest news
in the small
hospital
market
covered on
the next
slide:
4. • Founded as Dairyland in 1981 in Minnesota, Healthland grew
rapidly among small hospitals in the Midwest. They were
acquired in 2007 by Francisco Partners, who then sold them to
Evident in 2015 for $250M – probably quite a handsome profit!
- Healthland has about 350 small hospital clients, about
half on their “Classic” system, and half on the newer
“Centriq” system – a large target for Evident sales.
• Between CPSI’s client base of ≈650 hospitals, and Healthland’s
≈350 clients, Evident now has about 1,000 of the nation’s small
hospitals, making them the dominant player in this market niche.
• Evident also boasts an extremely strong sales & marketing team
led by VP Troy Rosser, so they will very likely turn around their
revenue drop in 2015 as the ≈175 hospitals on Healthland’s older
“Classic” system begin to replace their aging HIS & EMR during
the next 2 years that Evident has committed to support it...
acquires !
5. Below is the approximate # of clients on Evident’s “Thrive” (formerly
“The CPSI System”) and Healthland’s Classic & Centriq systems:
Evident Client Base
6. • Compared to the bewildering array of products from giants like
McKesson, Cerner/Siemens, and Meditech, Evident is simple:
Evident’s Products & Prospects
- They sell “Thrive,” period.
- Saving them a ton of money on
marketing staff, brochures, ppt
slides, proposals, contracts, etc.
• According to Evident’s press release in November of 2015, Evident
only intends to support the older Healthland “Classic” system for
2 years, whereas the newer “Centriq” system for 7 years.
• So we’re pretty bullish on them remaining on top of the small
vendor market for quite some time, as Troy’s sharp team has
unfettered access to the C-suite of hundreds of Healthland clients,
just like Cerner is getting so many Siemens clients on Invision,
Medseries4 and Soarian to drink the “Kansas City Kool-aid.”
7. • NextGen is a major player in the physician practice market with
about a half-billion $s in revenue from >40K physician practice
clients. They bought their way into the small-sized hospital
market a few years ago, by acquiring two small HIS vendors:
• NextGen targeted CAHes with their Opus/Sphere combo, sold a
few, and then surprised everyone by selling these systems to
QuadraMed (now a division of N. Harris) earlier this year.
• (We’ve heard rumors NextGen is starting a consulting division
that will target sales to the C-Suites of physician practice vendors
like athenahealth and eClinicalWorks entering the HIS market…)
- Opus– a solid EHR piloted by hospital
chain Universal Health Systems (UHS).
- Sphere – Florian Weiland’s rock-solid
financial systems, both RCM & ERP.
Sells Their HIS!
8. - Medhost – with a large
number of <100 bed clients in
Nashville-area chains like CHS.
- Meditech – whose Release 6 is
a logical alternative for Magic
and Client/Server clients.
- Cerner – whose Community
Works shares a system among
many CAH/small hospitals.
Other players in the small hospital market…
• If you’re a small hospital with under 100 beds, there are a number
of the larger vendors besides Evident that we reviewed in earlier
episodes, that you could consider in a search for a new system:
- Allscripts – who now offers
“Community Pricing” for
Sunrise in small hospitals.
- Paragon – McKesson’s “go
forward” product has many
very satisfied CAH clients.
- Epic – offers their “Epic-
Connect” through
neighboring IDNs & AMCs.
• Why are so many large vendors interested in the small hospital
market? For the same reason that Cadillac, BMW & Mercedes-
Benz offer smaller versions of their luxury cars: market share!
9. • Interesting how two of the leading physician practice vendors
entered the hospital HIS market the same year NextGen left:
– Athenahealth - acquired RazorInsights with ≈30 CAH clients.
Athenahealth is a major player in the physician practice
market with over 60K providers, and claims they have 4 CAH
clients already live on their “integrated” HIS/EHR…
– eClinicalWorks – another major player in the MD market
claims to have 80 hospitals in India & Africa using their access
and billing systems, with 8 US hospitals serving as pilots…
• They will now compete with Epic et al, by playing in both markets
with an integrated system for hospitals & physician practices. The
key question to evaluate them is whether they are truly integrated
(same programming language, DB and OS) or a screen-scraped,
API interface between disparate systems (interfarce?). For sure,
their web sites, proposals & ppt files are seamlessly integrated…
Latest Entrants into Small Market
10. • There are two other small-hospital players worth a quick review,
as they may follow RazorInsights path to large player status:
– Prognosis – officially known as “Prognosis Innovations
Healthcare,” they were formed in Houston in 2006 by the
former CMIO from Baylor. Their “ChartAcess” EHR & clinicals
is backed by a full suite of financial systems: RCM & ERP. Their
apps are not as robust as major HIS vendors, but their price is
as low as the needs of a CAH with a single-digit census…
– CSS / ORMED – Formed by “CSS HealthTech,” a small hospital
player with a wide array of clinical & financial systems, being
acquired by ORMED, a leading provider of ERP systems. Sadly,
last year they stopped selling their EHR, concentrating
instead on ORMED’s excellent price-performance ERP suite…
• Wonder which physician practice vendors might acquire either of
them, and launch another “integrated” solution in the future?
Up And Comers
11. Recap
• So there it is, a review of the leading HIS vendors for 2016,
separated into their three primary target hospital markets:
– Large hospitals >300 beds, AMCs & IDNs, who buy:
• Cerner, Epic, & Allscripts
– Mid-sized community hospitals from 1-300 beds, who buy:
• Meditech, Paragon, NTT Data, Medhost & QuadraMed
– Small hospitals under 100 beds, and CAH sites, who generally buy:
• Evident (CPSI/Healthland) and now athenahealth & eClinicalWorks
• Thanks to HIStalk for taking so much of their valuable blog space
with our annual ramblings. In case you have any questions,
comments, or your attorneys want our contact information:
- vciotti@hispros.com spouzar@hispros.com
505.466.4958 407.321.1110